Bill Few Associates’s Thermo Fisher Scientific TMO Stock Holding History

Bill Few Associates’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$260K	Buy	518 +5	+1%	+$2.4K	0.06%	197
2026 Q1	$252K	Sell	513 -10	-2%	-$5.43K	0.06%	191
2025 Q4	$303K	Sell	523 -109	-17%	-$61.6K	0.07%	156
2025 Q3	$307K	Buy	632 +44	+7%	+$20.5K	0.08%	150
2025 Q2	$238K	Buy	588 +35	+6%	+$14.6K	0.07%	168
2025 Q1	$275K	Hold	553	–	–	0.1%	145
2024 Q4	$288K	Hold	553	–	–	0.1%	141
2024 Q3	$342K	Hold	553	–	–	0.12%	127
2024 Q2	$306K	Hold	553	–	–	0.12%	129
2024 Q1	$321K	Hold	553	–	–	0.13%	121
2023 Q4	$294K	Buy	+553	New	+$268K	0.13%	122
2023 Q3	–	Sell	-384	Closed	-$200K	–	141
2023 Q2	$200K	Hold	384	–	–	0.1%	132
2023 Q1	$221K	Hold	384	–	–	0.12%	119
2022 Q4	$211K	Sell	384 -15	-4%	-$7.95K	0.12%	120
2022 Q3	$202K	Hold	399	–	–	0.14%	112
2022 Q2	$217K	Hold	399	–	–	0.14%	110
2022 Q1	$236K	Hold	399	–	–	0.13%	110
2021 Q4	$266K	Buy	+399	New	+$249K	0.14%	102

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bill Few Associates's TMO Position: Q2 2026 in Review

Bill Few Associates increased its Thermo Fisher Scientific (TMO) stake by 0.97% in Q2 2026, buying an estimated $2.4K and bringing the position to 518 shares worth $260K. The position accounts for 0.06% of the portfolio, ranked #197.

Bill Few Associates first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $342K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Bill Few Associates held 518 shares of Thermo Fisher Scientific worth $260K as of Q2 2026.
Bill Few Associates bought 5 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.4K.
Thermo Fisher Scientific made up 0.06% of Bill Few Associates's portfolio in Q2 2026, its #197 holding.
Bill Few Associates first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
Bill Few Associates's Thermo Fisher Scientific position peaked at $342K in Q3 2024.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Bill Few Associates's 13F filing for Q2 2026, filed 7 Jul 2026.